» Articles » PMID: 35818175

Specific Features of Ex-obese Patients Significantly Influence the Functional Cell Properties of Adipose-derived Stromal Cells

Overview
Journal J Cell Mol Med
Date 2022 Jul 12
PMID 35818175
Authors
Affiliations
Soon will be listed here.
Abstract

Adipose-derived stromal cells (ADSC) are increasingly used in clinical applications due to their regenerative capabilities. However, ADSC therapies show variable results. This study analysed the effects of specific factors of ex-obese patients on ADSC functions. ADSC were harvested from abdominal tissues (N = 20) after massive weight loss. Patients were grouped according to age, sex, current and maximum body mass index (BMI), BMI difference, weight loss method, smoking and infection at the surgical site. ADSC surface markers, viability, migration, transmigration, sprouting, differentiation potential, cytokine secretion, telomere length and mtDNA copy number were analysed. All ADSC expressed CD73, CD90, CD105, while functional properties differed significantly among patients. A high BMI difference due to massive weight loss was negatively correlated with ADSC proliferation, migration and transmigration, while age, sex or weight loss method had a smaller effect. ADSC from female and younger donors and individuals after weight loss by increase of exercise and diet change had a higher activity. Telomere length, mtDNA copy number, differentiation potential and the secretome did not correlate with patient factors or cell function. Therefore, we suggest that factors such as age, sex, increase of exercise and especially weight loss should be considered for patient selection and planning of regenerative therapies.

Citing Articles

Growth factors IGF-1 and KGF and adipose-derived stem cells promote migration and viability of primary human keratinocytes in an wound model.

Stadelmann N, Horch R, Schmid R, Ostendorf D, Peddi A, Promny T Front Med (Lausanne). 2025; 12:1516116.

PMID: 39981084 PMC: 11839819. DOI: 10.3389/fmed.2025.1516116.


Exosomes derived from minor salivary gland mesenchymal stem cells: a promising novel exosome exhibiting pro-angiogenic and wound healing effects similar to those of adipose-derived stem cell exosomes.

Xiang H, Ding P, Qian J, Lu E, Sun Y, Lee S Stem Cell Res Ther. 2024; 15(1):462.

PMID: 39627883 PMC: 11616330. DOI: 10.1186/s13287-024-04069-5.


Special Issue "Plastic and Reconstructive Surgery in Personalized Medicine".

Horch R, Arkudas A J Pers Med. 2023; 13(3).

PMID: 36983750 PMC: 10059863. DOI: 10.3390/jpm13030569.


Specific features of ex-obese patients significantly influence the functional cell properties of adipose-derived stromal cells.

Schmitz D, Robering J, Weisbach V, Arkudas A, Ludolph I, Horch R J Cell Mol Med. 2022; 26(16):4463-4478.

PMID: 35818175 PMC: 9357603. DOI: 10.1111/jcmm.17471.

References
1.
Christy B, Herzig M, Montgomery R, Delavan C, Bynum J, Reddoch K . Procoagulant activity of human mesenchymal stem cells. J Trauma Acute Care Surg. 2017; 83(1 Suppl 1):S164-S169. DOI: 10.1097/TA.0000000000001485. View

2.
Strong A, Cederna P, Rubin J, Coleman S, Levi B . The Current State of Fat Grafting: A Review of Harvesting, Processing, and Injection Techniques. Plast Reconstr Surg. 2015; 136(4):897-912. PMC: 4833505. DOI: 10.1097/PRS.0000000000001590. View

3.
Hass R, Kasper C, Bohm S, Jacobs R . Different populations and sources of human mesenchymal stem cells (MSC): A comparison of adult and neonatal tissue-derived MSC. Cell Commun Signal. 2011; 9:12. PMC: 3117820. DOI: 10.1186/1478-811X-9-12. View

4.
Jin Y, Yang L, Zhang Y, Gao W, Yao Z, Song Y . Effects of age on biological and functional characterization of adipose‑derived stem cells from patients with end‑stage liver disease. Mol Med Rep. 2017; 16(3):3510-3518. DOI: 10.3892/mmr.2017.6967. View

5.
Efimenko A, Dzhoyashvili N, Kalinina N, Kochegura T, Akchurin R, Tkachuk V . Adipose-derived mesenchymal stromal cells from aged patients with coronary artery disease keep mesenchymal stromal cell properties but exhibit characteristics of aging and have impaired angiogenic potential. Stem Cells Transl Med. 2013; 3(1):32-41. PMC: 3902283. DOI: 10.5966/sctm.2013-0014. View